Please assess the completion status of the following clinical trial:

Trial Title: Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least one year~* Age 7-21 years~* Attendee of Camp De Los Ninos or Conrad Chinnock~* Come to camp with a consent already signed after having talked to study staff about the study, or at the onset of the camp meet with study staff and sign the consent before the first night at camp.~* Using multiple daily insulin injections (Lantus) or on an insulin pump (any brand)~Exclusion Criteria:~* Cystic fibrosis~* Medications such as current use of oral steroids or other medications, which in the judgment of the investigator would be a contraindication to participation in the study.~* History of adhesive allergies which would interfere with sensor wear.

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Mini-Glucagon and Remote Monitoring (Type: EXPERIMENTAL): Subjects glucose data are remotely monitored at night using the University of Virginia (UVA) Diabetes Assistant (DiAs) Android Platform. Study staff intervenes with a fingerstick blood glucose measurement when sensor value falls below 70mg/dL. If fingerstick value is less than 70 mg/dL, hypoglycemic treatment is administered as below.~Administer mini-glucagon as treatment for nocturnal hypoglycemia. Administer 0.01 cc per number of years in age via insulin syringe, subcutaneously. This amounts to 1 unit per age, for example: an 8 year old gets 8 units glucagon.
- Carbohydrates and Remote Monitoring (Type: OTHER): Subjects glucose data are remotely monitored at night using the University of Virginia (UVA) Diabetes Assistant (DiAs) Android Platform. Study staff intervenes with a fingerstick blood glucose measurement when sensor value falls below 70mg/dL. If fingerstick value is less than 70 mg/dL, hypoglycemic treatment is administered as below.~Administration of carbohydrate per camp protocol to treat nocturnal hypoglycemia. Expected treatment is 15-45g.
- Carbohydrates No Remote Monitoring (Type: OTHER): Subjects wear a continuous glucose monitor for their own use, but they are not remotely monitored.~If hypoglycemia occurs and is acknowledged through standard camp protocol it will be treated with standard camp protocol administration of carbohydrates. Expected treatment is 15g-45g.
- Mini-Glucagon and No Remote Monitoring (Type: OTHER): Subjects wear a continuous glucose monitor for their own use, but they are not remotely monitored.~If hypoglycemia occurs and is acknowledged through standard camp protocol it will be treated with mini-glucagon.~Administer mini-glucagon as treatment for nocturnal hypoglycemia. Administer 0.01 cc per number of years in age via insulin syringe, subcutaneously. This amounts to 1 unit per age, for example: an 8 year old gets 8 units glucagon.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete